A cooperative initiative for individuals with congenital heart disease
Official title: The Co-Op @ HeartWorks
Run by HeartWorks, Inc. · NCT06469918 · Data updated 2026-11-12
This study is trying to gather information from people with congenital heart defects, especially those with Hypoplastic Left Heart Syndrome, to help improve their care and treatment options in the future.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 0 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | HeartWorks, Inc. Academic / other |
| Locations | 1 site (Rochester, Minnesota) |
| Status | Recruiting |
| Started | January 24, 2024 |
| Main results expected | January 1, 2050 |
| Study ends | January 1, 2050 |
| Registry record updated | October 7, 2025 |
| Trial ID | NCT06469918 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults with congenital heart defects, caregivers of minors with such conditions, and authorized family members of deceased individuals who had congenital heart disease.
✕Probably not a fit
Patients without a congenital heart defect or disease will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Co-Op @ HeartWorks is an observational research initiative focused on individuals diagnosed with congenital heart defects, particularly those with Hypoplastic Left Heart Syndrome (HLHS). This program aims to create a comprehensive database of medical journey data contributed by members of the congenital heart disease community. Participants, referred to as 'members', will actively engage in informing and shaping future clinical innovations and trials based on their experiences and needs. This collaborative approach seeks to enhance the care and treatment options available for patients with congenital heart disease.
Why it matters
Potential benefit: If successful, this initiative could lead to improved clinical trials and treatment options tailored to the specific needs of congenital heart disease patients.
How similar studies have gone: While this approach is innovative in its cooperative model, similar studies have shown success in utilizing patient data to inform clinical practices.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult with a congenital heart defects/disease * Caregiver of a minor with a congenital heart defect/disease * Authorized family member of a now deceased person with congenital heart defect/disease Exclusion Criteria: \- Not having a congenital heart defect/disease
Where it's running
-
HeartWorks, Inc.
Rochester, Minnesota, United States Recruiting
Study contacts
- Study coordinator: Adam Armstrong
- Email: adam@webuildhearts.org
- Phone: (507) 577-1764
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Adapting and testing PEN-Plus in Zambian primary care
Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.
-
Wireless NIRS Sensor Use in the NICU for Monitoring on Neonates
A wireless NIRS sensor is tested on infants in the NICU to see how well it stays on and how it notes brain signals when used alongside standard wired sensors.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Prehabilitation before heart surgery for adults with congenital heart disease
This study is testing whether a tailored, supervised exercise program before heart surgery helps adults with congenital heart disease perform better and improve fitness.
-
Accessible care model comparing nurse-led versus physician-led transition education for teens and young adults with congenital heart disease
This project will test whether an accessible care model and nurse-led versus physician-led transition education helps teens and young adults (ages 12–26) with congenital heart disease move successfully from pediatric to adult heart care.
-
Surgical techniques and outcomes across the lifespan in congenital heart disease in China
See which surgical factors and care patterns affect recovery after heart surgery for people with complex congenital heart disease in China.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.